Viewing StudyNCT00256711



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00256711
Status: COMPLETED
Last Update Posted: 2009-04-23
First Post: 2005-11-20

Brief Title: Phase II Iressa Versus Vinorelbine INVITE
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Non-Small-Cell Lung Carcinoma
Keywords:
Name View
Stage IIIb or Stage IV lung cancer View
Locally advanced or metastatic NSCLC View